BackAileron Therapeutics Overview

Aileron Therapeutics Total Assets

Latest total assets for ALRN: $66M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$65.97M
14.78% YoYΔ $8.49M vs prior year quarter

Peer trimmed avg / median

Loading

Aileron Therapeutics Total Assets History

Loading

Aileron Therapeutics vs. peers: Total Assets Comparison

Loading

Aileron Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aileron Therapeutics (ALRN) FAQ

As of the most recent data (June 2026), ALRN shows a total assets of $66M. That compares with $57M in the prior-year period — up 14.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ALRN's total assets is now $66M (was $57M) — a 14.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Aileron Therapeutics is outperforming or lagging.

Tracking ALRN's total assets over time shows whether Aileron Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $66M That compares with $57M in the prior-year period — up 14.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Aileron Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $66M) with ownership activity and broader fundamentals.

Aileron Therapeutics's total assets is $66M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.